Last chance to save on Digiday Publishing Summit passes is February 9
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
P&G bets big on retail integration as CPGs question incrementality
As P&G doubles down on retail media, CPG brands debate if the massive spending delivers incremental growth or is merely a new, expensive retailer “tax.”
In Graphic Detail: Why TikTok still faces an uphill battle in the U.S.
TikTok’s existence in the U.S. under new ownership, isn’t as smooth sailing as it hoped, at least not yet.
‘There was a conversation’: Vita Coco rides out TikTok U.S. uncertainty with its safety nets built
Vita Coco treats TikTok uncertainty as a cost of doing business, not a reason to leave.